Human monocytes kill M-CSF-expressing glioma cells by BK channel activation

Laboratory Investigation

Volumn 87, Issue 2, 2007, Pages 115-129

  Hoa, Neil T ^a   Zhang, Jian Gang ^a,b   Delgado, Christina L ^a   Myers, Michael P ^c   Callahan, Linda L ^c   Vandeusen, Gerald ^c   Schiltz, Patric M ^d   Wepsic, H Terry ^a,b   Jadus, Martin R ^a,b,e  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CALIFORNIA STATE UNIVERSITY   (United States)

^d HOAG MEMORIAL HOSPITAL PRESBYTERIAN   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Macrophage colony stimulating factor; Monocytes; Paraptosis; Potassium channels; Reactive oxygen species

Indexed keywords

COLONY STIMULATING FACTOR 1; IBERIOTOXIN; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; PHLORETIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; VIRUS VECTOR;

ARTICLE; CELL MEMBRANE; CELL ORGANELLE; CELL SWELLING; CELL VACUOLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; ENDOPLASMIC RETICULUM; FLUORESCENCE MICROSCOPY; GLIOMA CELL; HUMAN; HUMAN CELL; MITOCHONDRION; MONOCYTE; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY BURST;

CELL DEATH; CELL LINE, TUMOR; DITERPENES; DNA PRIMERS; ELECTROPHYSIOLOGY; GLIOMA; HOMEOSTASIS; HUMANS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MACROPHAGE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; MONOCYTES; PEPTIDES; PHLORETIN; POTASSIUM; RESPIRATORY BURST; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TIME FACTORS;

EID: 33847194691     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700506     Document Type: Article

References (58)

1. Sperandio S, de Belle I, Bredesen DE. An alternative, non-apoptotic form of programmed cell death. Proc Natl Acad Sci USA 2000;97:14376-14381.
2. Lazarowski ER, Homolya L, Boucher RC, et al. Direct demonstration of mechanically induced release of cellular UTP and its implication for uridine nucleotide receptor activation. J Biol Chem 1997;272:24348-24354.
3. Yang H, Wang H, Czura CJ, et al. The cytokine activity of HGMB1. J Leukocyte Biol 2005;78:1-8.
4. Melcher A, Todryk S, Hardwick N, et al. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med 1998;4:581-587.
5. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999;5:1249-1255.
6. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001;13:114-119.
7. Wylie AH, Kerr JFR, Currie AR. Cell death: the significance of apopotosis. Int Rev Cytol 1980;68:251-306.
8. Cohen JJ. Apoptosis. Immunol Today 1993;14:126-130.
9. Witham TF, Erff ML, Okada H, et al. 7-Hydroxystaurosporine-induced apoptosis in 9L glioma cells provides an effective antigen source for dendritic cells and yields a potent vaccine strategy in an intracranial glioma model. Neurosurgery 2002;50:1327-1334.
10. Barker RN, Erwig L, Pearce WP, et al. Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages. Pathobiology 1999;67:302-305.
11. Voll RE, Herrmann M, Roth EA, et al. Immunosuppressive effects of apoptotic cells. Nature 1997;390:350-351.
12. Steinman RM, Turley S, Mellman I, et al. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000;191:411-416.
13. Sauter B, Albert ML, Francisco L, et al. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000;191:423-433.
14. Fadok VA, Bratton DL, Konowaal A, et al. Macrophages that have ingested apoptotic cells in vitro inhibit pro-inflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2 and PAF. J Clin Invest 1998;101:890-898.
15. Reiter I, Krammer B, Schwamberger G. Differential effect of apoptotic vs necrotic tumor cells on macrophage anti-tumor activities. J Immunol 1999;163:1730-1732.
16. Jadus MR, Chen Y, Boldaji MT, et al. Human U251MG glioma cells expressing the membrane form of macrophage colony-stimulating factor (mM-CSF) are killed by human monocytes in vitro and are rejected within immunodeficient mice via paraptosis that is associated with increased expression of three different heat shock proteins. Cancer Gene Ther 2003;10:411-420.
17. Weaver AK, Liu X, Sontheimer H. Role for calcium-activation channels (BK) in growth control of human malignant glioma cells. J Neurosci Res 2004;78:224-234.
18. Ransom CB, Sontheimer H. BK channels in human glioma cells. J Neurophysiol 2001;85:790-801.
19. Liu X, Chang Y, Reinhart PH, et al. Cloning and characterization of glioma BK, a novel BK channel isoform highly expressed in human glioma cells. J Neurosci 2002;22:1840-1849.
20. Hoshi T, Lahiri S. Oxygen sensing: it's a gas. Science 2004;306:2050-2051.
21. Williams SE, Wootton P, Mason HS, et al. Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science 2004;306:2093-2097.
22. 2+ in CD34+ cell line KG-1a. Exp Hematol 2002;31:9-15.
23. Spergel DJ, Catt KJ, Rojas E. Immortalized GnRH neurons express large-conductance calcium-activated potassium channels. Neuroendocrinology 1996;63:101-111.
24. + channels in kidney epithelia. Biochim Biophys Acta 2005;1714:114-124.
25. Ransom CB, Xiaojin L, Sontheimer H. BK channels in human glioma cells have enhanced calcium sensitivity. Glia 2002;38:281-291.
26. Debska G, Kicinska A, Dobrucki J, et al. Large-conductance K+ channel openers NS1619 and NS004 as inhibitors of mitochondrial function in glioma cells. Biochem Pharm 2003;65:1827-1834.
27. Debska G, Kicinska A, Skalska J, et al. Intracellular potassium and chloride channels: an update. Acta Biochimica Polonica 2001;48:137-144.
28. Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 2004;4:941-952.
29. Serafini P, Borrello I, Bronte V. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol 2006;16:53-65.
30. Grzelak A, Rychlik B, Bartosz G. Light-dependent generation of reactive oxygen species in cell culture media. Free Radical BioMed 2001;30:1418-1425.
31. Hamill OP, Marty A, Neher E, et al. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981;391:85-100.
32. Molleman A. Patch Clamping. Wiley Press: West Sussex, England, 2003.
33. Myers MP, Yang J, Stampe P. Visualization and functional analysis of a maxi-K channel (mSlo) fused to green fluorescent protein (GFP). Electronic J Biotechnol (online) 1999;2:3 www.ejbiotechnology.info/content/vol2/issue3/full/ 3/index.html.
34. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
35. Jadus MR, Irwin MC, Irwin MR, et al. Macrophages can recognize and kill tumor cells bearing the membrane isoform of macrophage colony-stimulating factor. Blood 1996;87:5232-5241.
36. Dan Q, Sanchez R, Delgado C, et al. Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8 T cell immunity against the parental tumor. Mol Ther 2001;4:427-437.
37. Chen Y, Xu Q, Williams CC, et al. Living T9 glioma cancer cells expressing membrane macrophage colony stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes, and macrophages via a 'paraptosis'-induced pathway that promotes systemic immunity against intracranial T9 gliomas. Blood 2002;100:1373-1380.
38. Graf MR, Jadus MR, Wepsic HT, et al. Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane bound isoform of macrophage colony stimulating factor (CSF-1). J Immunol 1999;163:5544-5551.
39. Sanchez R, Williams CC, Daza JL, et al. T9 glioma cells expressing membrane macrophage colony stimulating factor produce CD4+ associated protective immunity against T9 intracranial gliomas and systemic immunity against different syngeneic gliomas. Cell Immunol 2002;216:1-10.
40. Williams CC, Trinh H, Tran TV, et al. Membrane expression of macrophage colony stimulating factor on MADB106 breast cancer cells is not associated with in vitro cytotoxicity by macrophages but is associated with the induction lasting tumor immunity against syngeneic breast cancer cells in vivo. Mol Ther 2001;3:216-221.
41. Scholl SM, Pallud C, Beuvon F, et al. Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. JNCI 1994;86:120-126.
42. Ramakrishnan S, Xu FJ, Brandt SJ, et al. Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. J Clin Invest 1989;83:921-926.
43. Chunhai H, Parney IF, Roa WH, et al. Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation. Acta Neuropathol 2002;103:171-178.
44. Jadus MR, Wepsic HT, Jeffes EWB. The biology and potential anticancer uses of the membrane form of macrophage colony stimulating factor. Recent Res Dev Immunol 1999;1:267-281.
45. Rao RV, Ellerby HM, Bredesen DE. Coupling endoplasmic reticulum stress to the cells death program. Cell Death and Different 2004;11:373-380.
46. Jambrina E, Alonso R, Alcada M, et al. Calcium influx through receptor-operated channel induces mitochondria-triggered paraptotic cell death. J Biol Chem 2004;278:14134-14145.
47. Cassel D, Katz M, Rotman M. Depletion of cellular ATP inhibits Na+/H+ antiport in cultured human cells. J Biol Chem 1986;261:5460-5466.
48. Schneider D, Gerhardt E, Bock J, et al. Intracellular acidification by inhibition of the Na+/H+-exchanger leads to caspase-independent death of cerebellar granule neurons resembling paraptosis. Cell Death Differ 2004;11:760-770.
49. Nioctera P, Melino G. Regulation of the apoptosis-necrosis switch. Oncogene 2004;23:2757-2765.
50. Eguchi Y, Shimuzu S, Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 1997;57:1835-1840.
51. Nicotera P, Leist M, Fava E, et al. Energy requirement for caspase activation and neuronal cell death. Brain Pathol 2000;10:276-282.
52. Leist M, Single B, Castoldi AF, et al. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997;185:1481-1486.
53. Simon F, Varela D, Riveros A, et al. Non-selective cation channels and oxidative stress-induced cell swelling. Biol Res 2002;35:215-222.
54. Estevez AG, Radi R, Barbeito L, et al. Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J Neurochem 1995;65:1543-1550.
55. Dutta AK, Okada Y, Sabirov RZ. Regulation of an ATP-conductive large-conductance anion channel and swelling-induced ATP release by arachidonic acid. J Physiol 2002;542.3:803-816.
56. Winkler AS, Baethmann A, Peters J, et al. Mechanisms of arachidonic acid induced glial swelling. Mol Brain Res 2000;76:419-423.
57. Peters-Golden M, McNish RW, Hyzy R, et al. Alterations in the pattern of arachidonate metabolism accompany rat macrophage differentiation in the lung. J Immunol 1990;144:263-270.
58. 2-induced cell swelling in distal nephron segments. Am J Physiol 1992;263:F824-F832.